Inovio Pharmaceuticals
INO
#9778
Rank
C$0.11 B
Marketcap
C$1.44
Share price
-3.77%
Change (1 day)
-32.51%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): C-$3.16

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$3.20. In 2025 the company made an earnings per share (EPS) of C-$2.55 an increase over its 2024 EPS that were of C-$5.56.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.1624.17%
2025C-$2.55-54.18%
2024C-$5.56-35.14%
2023C-$8.57-56.62%
2022C-$19.77-19.54%
2021C-$24.5735.9%
2020C-$18.08-11.57%
2019C-$20.4415.24%
2018C-$17.74-2.78%
2017C-$18.256.93%
2016C-$17.06134.88%
2015C-$7.27-29.51%
2014C-$10.31-57.34%
2013C-$24.16146.55%
2012C-$9.8020.83%
2011C-$8.11-29.41%
2010C-$11.49-48.48%
2009C-$22.3010%
2008C-$20.2711.11%
2007C-$18.25-41.3%
2006C-$31.09-66.91%
2005C-$93.94110.61%
2004C-$44.60-61.63%
2003C-$116.24186.67%
2002C-$40.55
2001N/A-100%
2000C-$32.44-63.64%
1999C-$89.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.30-484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.88-409.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.84-157.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.45-426.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$5.03-257.48%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.47-271.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
C$1.14-135.68%๐Ÿ‡บ๐Ÿ‡ธ USA